Literature DB >> 22990857

p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO.

Yuri Shibata1, Masaaki Oyama, Hiroko Kozuka-Hata, Xiao Han, Yuetsu Tanaka, Jin Gohda, Jun-ichiro Inoue.   

Abstract

The persistent or excess activation of NF-κB causes various inflammatory and autoimmune diseases, but the molecular mechanisms that negatively regulate NF-κB activation are not fully understood. Here we show that p47, an essential factor for Golgi membrane fusion, associates with the NEMO subunit of the IκB kinase (IKK) complex upon TNF-α or IL-1 stimulation, and inhibits IKK activation. p47 binds to Lys63-linked and linear polyubiquitin chains, which are conjugated to NEMO upon such stimulation. The binding of p47 to polyubiquitinated NEMO triggers the lysosomal degradation of NEMO, thereby inhibiting IKK activation. The silencing of p47 results in enhanced TNF-α- or IL-1-induced IKK activation, and an increased expression of genes encoding inflammatory mediators. Taken together, our results suggest that p47 is critical for negatively regulating stimulation-induced IKK activation in a manner that is mechanistically distinct from the previously characterized negative regulators, such as A20 and CYLD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990857     DOI: 10.1038/ncomms2068

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  60 in total

Review 1.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

2.  The UBX domain: a widespread ubiquitin-like module.

Authors:  A Buchberger; M J Howard; M Proctor; M Bycroft
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

Review 3.  Expanding role of ubiquitination in NF-κB signaling.

Authors:  Siqi Liu; Zhijian J Chen
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

4.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

5.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Authors:  Daniel R Rhodes; Shanker Kalyana-Sundaram; Vasudeva Mahavisno; Radhika Varambally; Jianjun Yu; Benjamin B Briggs; Terrence R Barrette; Matthew J Anstet; Colleen Kincead-Beal; Prakash Kulkarni; Sooryanaryana Varambally; Debashis Ghosh; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

6.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

7.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

8.  Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.

Authors:  David Komander; Francisca Reyes-Turcu; Julien D F Licchesi; Peter Odenwaelder; Keith D Wilkinson; David Barford
Journal:  EMBO Rep       Date:  2009-04-17       Impact factor: 8.807

9.  A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta.

Authors:  Ming Xu; Brian Skaug; Wenwen Zeng; Zhijian J Chen
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

10.  The Ubx2 and Ubx3 cofactors direct Cdc48 activity to proteolytic and nonproteolytic ubiquitin-dependent processes.

Authors:  Rasmus Hartmann-Petersen; Mairi Wallace; Kay Hofmann; Grete Koch; Anders H Johnsen; Klavs B Hendil; Colin Gordon
Journal:  Curr Biol       Date:  2004-05-04       Impact factor: 10.834

View more
  31 in total

Review 1.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

2.  Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis.

Authors:  Dulce C Macias-Ceja; Jesús Cosín-Roger; Dolores Ortiz-Masiá; Pedro Salvador; Carlos Hernández; Juan V Esplugues; Sara Calatayud; María D Barrachina
Journal:  Br J Pharmacol       Date:  2017-06-21       Impact factor: 8.739

3.  Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.

Authors:  Yu-Bo Wang; Bo Tan; Rui Mu; Yan Chang; Min Wu; Hai-Qing Tu; Yu-Cheng Zhang; Sai-Sai Guo; Xuan-He Qin; Tao Li; Wei-Hua Li; Ai-Ling Li; Xue-Min Zhang; Hui-Yan Li
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

4.  p47 licenses activation of the immune deficiency pathway in the tick Ixodes scapularis.

Authors:  Erin E McClure Carroll; Xiaowei Wang; Dana K Shaw; Anya J O'Neal; Adela S Oliva Chávez; Lindsey J Brown; Vishant Mahendra Boradia; Holly L Hammond; Joao H F Pedra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

Review 5.  The cellular autophagy/apoptosis checkpoint during inflammation.

Authors:  Jeannette S Messer
Journal:  Cell Mol Life Sci       Date:  2016-11-11       Impact factor: 9.261

6.  The Emerging Role of Astrocytic Autophagy in Central Nervous System Disorders.

Authors:  Zhuchen Zhou; Jing Zhou; Jie Liao; Zhong Chen; Yanrong Zheng
Journal:  Neurochem Res       Date:  2022-08-12       Impact factor: 4.414

Review 7.  Autophagy in infection, inflammation and immunity.

Authors:  Vojo Deretic; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Rev Immunol       Date:  2013-10       Impact factor: 53.106

8.  EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.

Authors:  Jian Fu; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

Review 9.  The IκB kinase complex in NF-κB regulation and beyond.

Authors:  Michael Hinz; Claus Scheidereit
Journal:  EMBO Rep       Date:  2013-12-27       Impact factor: 8.807

10.  Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Authors:  S H Han; S-H Kim; H-J Kim; Y Lee; S-Y Choi; G Park; D-H Kim; A Lee; J Kim; J-M Choi; Y Kim; K Myung; H Kim; D-W Kim
Journal:  Leukemia       Date:  2017-02-24       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.